Coeptis Therapeutics Hldgs Inc (COEP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,877 | -21,267 | -37,574 | -13,449 | -17,280 |
| Depreciation Amortization | 1,217 | 1,001 | 1,001 | 447 | N/A |
| Accounts receivable | 0 | 8 | -8 | 22 | N/A |
| Accounts payable and accrued liabilities | -150 | 1,321 | -35 | -1,578 | N/A |
| Other Working Capital | -125 | 1,727 | -550 | -2,980 | -47 |
| Other Operating Activity | 3,286 | 9,970 | 33,291 | 13,049 | 17,211 |
| Operating Cash Flow | $-6,649 | $-7,240 | $-3,876 | $-4,489 | $-116 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | N/A | N/A | N/A | N/A | -75,750 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -1,750 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -1,750 | 0 |
| Investing Cash Flow | $N/A | $N/A | $0 | $-1,750 | $-75,750 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 42 |
| Debt Issued | 1,850 | 650 | 0 | 78 | N/A |
| Debt Repayment | -651 | -1,225 | -2,417 | -1,700 | N/A |
| Common Stock Issued | 600 | 5,492 | 8,519 | 10,137 | 77,250 |
| Common Stock Repurchased | N/A | N/A | N/A | -247 | N/A |
| Other Financing Activity | 3,914 | 0 | -615 | -51 | -520 |
| Financing Cash Flow | $5,713 | $4,917 | $5,488 | $8,216 | $76,772 |
| Beginning Cash Position | 1,469 | 3,791 | 2,180 | 203 | 1 |
| End Cash Position | 533 | 1,469 | 3,791 | 2,180 | 907 |
| Net Cash Flow | $-936 | $-2,322 | $1,612 | $1,977 | $907 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,649 | -7,240 | -3,876 | -4,489 | -116 |
| Free Cash Flow | -6,649 | -7,240 | -3,876 | -4,489 | -116 |